New Hampshire STEM News
SEE OTHER BRANDS

Fresh science and technology news from New Hampshire

New Hampshire STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire STEM News.

Press releases published on September 5, 2025

Gothika Partners with 'Godfather of Fangs' Scott Smiledge to Launch Revolutionary Custom-Fit Vampire Fangs

Gothika Partners with 'Godfather of Fangs' Scott Smiledge to Launch Revolutionary Custom-Fit Vampire Fangs

Industry-Leading Contact Lens Company Introduces Game-Changing At-Home Fang Technology That Eliminates Need for Glues and Adhesives STRATHAM, NH, UNITED STATES, September 5, 2025 /⁨EINPresswire.com⁩/ -- Gothika, a pioneering force in the Halloween contact …

Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025

Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025

$10.7 Million Repaid Year to Date and $32.7 Million Since September 2024 Obligation Debt Reduction Initiatives Adding Material Benefit to Net Income and Shareholders’ Equity SEATTLE, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: …

Tiziana Life Sciences Announces Purchase of Shares by Chairman

Tiziana Life Sciences Announces Purchase of Shares by Chairman

BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …

24/7 Market News: Kraig Labs Fibers are 5X Stronger Than Steel, Tougher than Kevlar, and Biodegradable

24/7 Market News: Kraig Labs Fibers are 5X Stronger Than Steel, Tougher than Kevlar, and Biodegradable

DENVER, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and insights, reports that Kraig Biocraft Laboratories (OTCQB: KBLB)(“Kraig Labs” or “the Company”), the …

Lowkick Studio Launches $SHARDS as WorldShards Expands to Global Audiences

Lowkick Studio Launches $SHARDS as WorldShards Expands to Global Audiences

Abu Dhabi, UAE, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Lowkick Studio has officially announced the launch of the $SHARDS token, the core of its upcoming Web3 MMORPG, WorldShards. The token generation event (TGE) coincides with listings on top-tier exchanges, …

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards …

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas J. Errico, MD, has …

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of …

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025

– 17 abstracts accepted, including one oral presentation – – Data from the REFRESH real-world study highlight efficacy of once-nightly sodium oxybate when switching from twice-nightly oxybates – – REFRESH study also highlights efficacy in those who were …

Geotab atinge 5 milhões de veículos conectados globalmente e reforça liderança em telemática

Geotab atinge 5 milhões de veículos conectados globalmente e reforça liderança em telemática

SÃO PAULO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- A Geotab anunciou a conquista de um novo marco: alcançou a marca de mais de 5 milhões de veículos conectados globalmente, reforçando sua liderança em telemática e soluções para o setor de transportes. O …

Youxin Technology Ltd Announces Pricing of $6.0 Million Underwritten Public Offering

Youxin Technology Ltd Announces Pricing of $6.0 Million Underwritten Public Offering

GUANGZHOU, CHINA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (NASDAQ: YAAS) (the “Company”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their …

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological …

Blocksize Exposes Hidden Custodial Staking Risks, Calls for Transparency and Governance to Secure Solana’s Future

Blocksize Exposes Hidden Custodial Staking Risks, Calls for Transparency and Governance to Secure Solana’s Future

Frankfurt, Germany, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Blocksize, a German-based DeFi infrastructure provider, is calling attention to the hidden fees of custodial staking platforms, which quietly erode yields, undermine governance, and place long-term …

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV® Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. …

NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board

NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board

Vancouver, B.C. , Sept. 05, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced its financial results for the fiscal year ended June 30, 2025, and provided a corporate update on its progress. …

Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie

Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie

EGRIFTA WRMC offre la commodité d’une reconstitution hebdomadaire et d’un volume d’injection quotidien réduit, comparativement à EGRIFTA SVMD Les pharmacies spécialisées commandent désormais EGRIFTA WRMC pour exécuter les ordonnances MONTRÉAL, 05 sept. …

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

~ All patients in the first cohort achieved between 27- to 208-fold increases in α-Gal A activity relative to mean normal level ~ ~ All patients in first cohort discontinued enzyme replacement therapy ~ ~ Preliminary data show AMT-191 has a manageable …

Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program

Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program

-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. -- -- Announced in advance of World Duchenne Awareness Day on …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions